ChiCTR2300076309 版本V1.0 版本创建时间2023/09/30 17:10:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300076309 

最近更新日期:

Date of Last Refreshed on:

2023-09-30 17:10:14 

注册时间:

Date of Registration:

2023-09-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

不同鞋重对变向旋转起跳对高台着地反弹跳运动能力的影响

Public title:

The Effect of Different Shoe Weights on the Ability of High Platform Landing Rebound Jump with Changing Direction Rotation Takeoff

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同鞋重对变向旋转起跳对高台着地反弹跳运动能力的影响

Scientific title:

The Effect of Different Shoe Weights on the Ability of High Platform Landing Rebound Jump with Changing Direction Rotation Takeoff

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王奕霖 

研究负责人:

王奕霖 

Applicant:

I-Lin Wang 

Study leader:

I-Lin Wang 

申请注册联系人电话:

Applicant telephone:

+86 139 4397 6987

研究负责人电话:

Study leader's telephone:

+86 139 4397 6987

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ilin.wang@hotmail.com

研究负责人电子邮件:

Study leader's E-mail:

ilin.wang@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

吉林省长春市南关区自由大路2476号

研究负责人通讯地址:

吉林省长春市南关区自由大路2476号

Applicant address:

2476 Ziyou Road, Nanguan District, Changchun, Jilin, China

Study leader's address:

2476 Ziyou Road, Nanguan District, Changchun, Jilin, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

吉林体育学院

Applicant's institution:

Jilin Sport University

研究负责人所在单位:

吉林体育学院

Affiliation of the Leader:

Jilin Sport University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

JLSU-IRB2023007

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

吉林体育学院人体研究伦理委员会

Name of the ethic committee:

JLSU-Joint Institutional Review Board

伦理委员会批准日期:

Date of approved by ethic committee:

2023-09-22 00:00:00

伦理委员会联系人:

王洪丹

Contact Name of the ethic committee:

Hongdan Wang

伦理委员会联系地址:

吉林省长春市南关区自由大路2476号吉林体育学院

Contact Address of the ethic committee:

2476 Ziyou Road, Nanguan District, Changchun, Jilin, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 139 4397 6987

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

吉林体育学院

Primary sponsor:

Jilin Sport University

研究实施负责(组长)单位地址:

吉林省长春市南关区自由大路2476号吉林体育学院

Primary sponsor's address:

Jilin Sport University, 2476, Freedom Road, Nanguan District

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

吉林

市(区县):

Country:

China

Province:

Jilin

City:

单位(医院):

吉林体育学院

具体地址:

吉林省长春市南关区自由大路2476号

Institution
hospital:

Jilin Sport University

Address:

No. 2476, Freedom Road, Nanguan District

经费或物资来源:

Source(s) of funding:

self-raised

Target disease:

The Effect of Different Shoe Weights on the Ability of High Platform Landing Rebound Jump with Changing Direction Rotation Takeoff

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机交叉对照 

Study design:

Cross-over 

研究目的:

探讨不同鞋重对变向旋转起跳对高台着地反弹跳运动能力的影响,不同鞋重引起的力矩、角度、功率,速度等参数的改变是否会对高台着地后变向剪切动作造成影响,增加运动损伤的风险。  

Objectives of Study:

Explore the impact of different shoe weights on the variable shear motion after landing on a high platform, and whether changes in parameters such as torque, angle, power, and speed caused by different shoe weights will affect the variable shear motion after landing on a high platform, increasing the risk of sports injury.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

选取至少30名血压正常的成年男性受试者作为研究对象,这些受试者的健康状况在参加实验前通过医院常规体检得以确认,并在此之前未参加过系统的运动训练。年龄介于 20-40 岁自愿参与本研究者。

Inclusion criteria

At least 30 adult male subjects with normal blood pressure, whose health status was confirmed by routine hospital examination prior to participation in the study, and who had not previously participated in systematic exercise training, were selected for the study. Those aged 20-40 years volunteered to participate in the study.

排除标准:

(1)年龄大于40岁者。 (2)高血压患者。 (3)下肢有伤病无法完成快速移动要求者。 (4)有中风、严重心脏病、糖尿病、神经肌肉疾患,以致无法参与身体活动者。 (5)心律不整、配带心律调节器、严重心血管疾病者。 (6)癫痫、类风湿性关节炎者。 (7)近六个月植入人工关节、近期手术者。 (8)实验前24小时内有从事剧烈运动或有肌肉酸痛情形者。 (9)实验期间因其他原因造成身体不适者。 (10)过度肥胖者 BMI>30,且受试者体重超过100公斤。

Exclusion criteria:

(1) Those over 40 years old. (2) Patients with hypertension. (3) Individuals with lower limb injuries who are unable to complete rapid movement requirements. (4) Those who have stroke, serious heart disease, diabetes, neuromuscular diseases, and are unable to participate in physical activities. (5) Individuals with irregular heart rhythm, equipped with rhythm regulators, and severe cardiovascular diseases. (6) People with epilepsy and rheumatoid arthritis. (7) Artificial joint implantation in the past six months and recent surgery. (8) Those who engage in intense exercise or experience muscle soreness within 24 hours before the experiment. (9) Individuals who experience physical discomfort due to other reasons during the experiment. (10) Obese individuals with a BMI>30 and subjects weighing over 100 kilograms.

研究实施时间:

Study execute time:

From 2023-10-02 00:00:00 To 2023-11-02 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-10-02 00:00:00 To 2023-11-02 00:00:00  

干预措施:

Interventions:

组别:

175g鞋重

样本量:

30

Group:

175 g shoe weight

Sample size:

干预措施:

穿着175g鞋重

干预措施代码:

Intervention:

Wearing 175 g shoe weight

Intervention code:

组别:

255g鞋重

样本量:

30

Group:

255 g shoe weight

Sample size:

干预措施:

穿着255g鞋重

干预措施代码:

Intervention:

Wearing 255 g shoe weight

Intervention code:

组别:

335g鞋重

样本量:

30

Group:

335 g shoe weight

Sample size:

干预措施:

穿着335g鞋重

干预措施代码:

Intervention:

Wearing 335 g shoe weight

Intervention code:

组别:

415g鞋重

样本量:

30

Group:

415 g shoe weight

Sample size:

干预措施:

穿着415g鞋重

干预措施代码:

Intervention:

Wearing 415 g shoe weight

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

吉林 

市(区县):

 

Country:

China 

Province:

Jilin 

City:

 

单位(医院):

吉林体育学院 

单位级别:

大学 

Institution
hospital:

Jilin Sport University

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

关节角度

指标类型:

主要指标

Outcome:

Joint angle

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

地面反作用力

指标类型:

主要指标

Outcome:

Ground reaction forces

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

力矩

指标类型:

主要指标

Outcome:

torque

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功率

指标类型:

主要指标

Outcome:

power

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 40 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

平衡次序法

Randomization Procedure (please state who generates the random number sequence and by what method):

counter balance method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

单盲

Blinding:

Single blinded

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

www.anygame123.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

www.anygame123.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

www.anygame123.com

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

www.anygame123.com

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-09-30 17:10:14